0007

Chengdu Huasun Technology Group Inc., Ltd. 000790

Market Closed
30 Sep, 06:57
XSHE XSHE
¥
4. 02
+0.28
+7.49%
¥
2.51B Market Cap
84.33 P/E Ratio
0.01% Div Yield
31,671,293 Volume
0 Eps
¥ 3.74
Previous Close
Day Range
3.78 4.09
Year Range
3.02 5.87

000790 Chart

Chengdu Huasun Technology Group Inc., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Mingliang Huang CEO
XSHE Exchange
CNE0000001H5 ISIN
CN Country
857 Employees
- Last Dividend
9 May 2019 Last Split
1 Jan 1990 IPO Date

Overview

Chengdu Huasun Technology Group Inc., LTD. is a diverse enterprise that plays a significant role in the pharmaceutical and construction industries. Originating in 1988 and previously known as Chengdu Taihe Health Technology Group Inc., Ltd., the company underwent a brand transformation in April 2020 to better reflect its broader technological and innovative aspirations. Based in the vibrant city of Chengdu, China, Chengdu Huasun is committed to the advancement of healthcare through the development, manufacture, and sale of a wide range of pharmaceutical products. Additionally, the company leverages its expertise in technology and engineering to offer comprehensive solutions for steel structure buildings, including design, production, installation, and maintenance services. This dual-focused approach enables Chengdu Huasun to contribute significantly to both medical science and the construction industry, emphasizing its role in improving human health and building infrastructures.

Products and Services

Chengdu Huasun Technology Group Inc., LTD. provides a diverse portfolio of products and services spanning the pharmaceutical and construction sectors:

  • Medicines and Pharmaceuticals:

    The company excels in the production of a wide range of pharmaceutical products, including modern Chinese medicines, Chinese patent medicines, chemical medicines, and various drugs aimed at improving health outcomes. By focusing on research and development, Chengdu Huasun continuously seeks to innovate and provide effective treatments for diseases, particularly those related to cardiovascular and cerebrovascular health.

  • Bio-pharmaceutical Products:

    Engaging in the cutting-edge field of biotechnology, Chengdu Huasun is involved in the development and manufacturing of biological products and biotech drugs. This endeavor underlines the company's commitment to leveraging scientific advancements for the creation of novel therapies and solutions that address complex medical challenges.

  • Steel Structure Buildings:

    Apart from its significant presence in the healthcare sector, Chengdu Huasun also specializes in the design, production, installation, and servicing of steel structure buildings. These services cater to a variety of applications, from commercial and industrial to residential buildings, demonstrating Chengdu Huasun’s capability in providing structurally sound, economically viable, and aesthetically pleasing construction solutions.

Contact Information

Address: No. 1168, Shuxin Avenue, Chengdu, China, 611731
Phone: 86 28 6769 2806